Global Pulmonary Arterial Hypertension (PAH) Market: Size,Trends and Forecast up to 2028

The report provides insight into the pulmonary arterial hypertension market based on the regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
DELHI, India - May 29, 2023 - PRLog -- The global pulmonary arterial hypertension market was valued at US$8.18 billion in 2022. The market value is expected to reach US$11.43 billion by 2028. Pulmonary arterial hypertension (PAH) is a rare and progressive disorder characterized by elevated blood pressure of more than 25mmHg in the arteries of the lungs, also known as the pulmonary artery. While PAH affects both genders, it is more prevalent among females aged 30-60 years. Unfortunately, there is no known cure for PAH, but various treatment options are available to manage symptoms and enhance patients' quality of life.

Scope of the Report:

-- An in-depth analysis of the global pulmonary arterial hypertension market by value, by drug class, by type, by route of administration, by distribution channel, by region, etc.

-- The regional analysis of the pulmonary arterial hypertension market, including the following regions:

North America (The US, Canada, and Mexico)
Europe (The UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of the Asia Pacific)
Latin America
Middle East & Africa

-- Comprehensive information about emerging markets. This report analyses the market for various segments across geographies.

-- Provides an analysis of the COVID-19 impact on the global pulmonary arterial hypertension market.

-- Assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall the pulmonary arterial hypertension market has also been forecasted for the period 2023-2028, taking into consideration the previous growth patterns, the growth drivers, and the current and future trends.

-- Evaluation of the potential role of the pulmonary arterial hypertension to improve the market status.

-- Identification of new technological developments, R&D activities, and product launches occuring in the pulmonary arterial hypertension market.

-- In-depth profiling of the key players, including the assessment of the business overview, market strategies, regional and business segments of the leading players in the market.

-- The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.

-- The in-depth analysis provides an insight into the market, underlining the growth rate and opportunities offered in the business.

For further details, kindly visit :

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID -

Rajeev Kumar
+91- 9811715635
Source: » Follow
Email:*** Email Verified
Tags:Pulmonary Arterial Market
Location:Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Daedal Research News
Most Viewed
Daily News

Like PRLog?
Click to Share